Rating Change
UBS analysts reiterated a Buy rating on McKesson Corporation (NYSE:MCK) on August 06, 2026.
reiterateNYSE:MCK
UBS Reiterates Buy Rating on McKesson Corporation (MCK)
Rating Change UBS analysts reiterated a Buy rating on McKesson Corporation (NYSE:MCK) on August 06, 2026. Market Context McKesson Corporation operates in the Healthcare sector.…
Market Context
McKesson Corporation operates in the Healthcare sector. The stock currently trades at $870.78 with a market capitalization of $102.0B. The stock has gained 3.3% over the past 52 weeks.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for McKesson Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for McKesson Corporation
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 06, 2026 | Evercore ISI Group | Outperform | N/A |
| Aug 06, 2026 | UBS | Buy | N/A |
| Aug 06, 2026 | TD Cowen | Buy | N/A |
| Jul 24, 2026 | Citigroup | Buy | N/A |
| Jul 21, 2026 | TD Cowen | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View MCK Stock Page
Frequently Asked Questions
What does a Buy rating mean for MCK?
A Buy rating from UBS reflects the analyst's outlook on McKesson Corporation (NYSE:MCK). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MCK forecast page.
